Annual Cost Of Goods Sold
$24.95 B
-$9.39 B-27.34%
31 December 2023
Summary:
Pfizer annual cost of goods sold is currently $24.95 billion, with the most recent change of -$9.39 billion (-27.34%) on 31 December 2023. During the last 3 years, it has risen by +$16.47 billion (+194.13%). PFE annual cost of goods sold is now -27.34% below its all-time high of $34.34 billion, reached on 31 December 2022.PFE Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$5.26 B
+$1.96 B+59.48%
30 September 2024
Summary:
Pfizer quarterly cost of goods sold is currently $5.26 billion, with the most recent change of +$1.96 billion (+59.48%) on 30 September 2024. Over the past year, it has dropped by -$4.01 billion (-43.22%). PFE quarterly cost of goods sold is now -47.29% below its all-time high of $9.98 billion, reached on 01 March 2022.PFE Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$19.50 B
-$4.01 B-17.04%
30 September 2024
Summary:
Pfizer TTM cost of goods sold is currently $19.50 billion, with the most recent change of -$4.01 billion (-17.04%) on 30 September 2024. Over the past year, it has dropped by -$7.54 billion (-27.87%). PFE TTM cost of goods sold is now -49.07% below its all-time high of $38.30 billion, reached on 01 June 2022.PFE TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.3% | -43.2% | -27.9% |
| 3 y3 years | +194.1% | -47.0% | -18.0% |
| 5 y5 years | +177.7% | +102.3% | +131.5% |
PFE Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.3% | +194.1% | -47.3% | +62.6% | -49.1% | at low |
| 5 y | 5 years | -27.3% | +209.8% | -47.3% | +1088.0% | -49.1% | +213.8% |
| alltime | all time | -27.3% | +1767.8% | -47.3% | +5813.5% | -49.1% | +4293.0% |
Pfizer Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.26 B(+59.5%) | $19.50 B(-17.0%) |
| June 2024 | - | $3.30 B(-2.3%) | $23.51 B(+0.3%) |
| Mar 2024 | - | $3.38 B(-55.3%) | $23.45 B(-6.0%) |
| Dec 2023 | $24.95 B(-27.3%) | $7.56 B(-18.4%) | $24.95 B(-7.7%) |
| Sept 2023 | - | $9.27 B(+186.3%) | $27.04 B(+13.5%) |
| June 2023 | - | $3.24 B(-33.7%) | $23.83 B(-18.5%) |
| Mar 2023 | - | $4.89 B(-49.4%) | $29.25 B(-14.8%) |
| Dec 2022 | $34.34 B(+11.4%) | $9.65 B(+59.1%) | $34.34 B(-0.3%) |
| Sept 2022 | - | $6.06 B(-29.9%) | $34.43 B(-10.1%) |
| June 2022 | - | $8.65 B(-13.4%) | $38.30 B(+4.5%) |
| Mar 2022 | - | $9.98 B(+2.5%) | $36.65 B(+18.9%) |
| Dec 2021 | $30.82 B(+263.3%) | $9.74 B(-2.0%) | $30.82 B(+29.5%) |
| Sept 2021 | - | $9.93 B(+42.0%) | $23.80 B(+49.9%) |
| June 2021 | - | $7.00 B(+68.3%) | $15.87 B(+48.3%) |
| Mar 2021 | - | $4.16 B(+53.3%) | $10.70 B(+26.1%) |
| Dec 2020 | $8.48 B(+5.3%) | $2.71 B(+35.1%) | $8.48 B(+36.5%) |
| Sept 2020 | - | $2.01 B(+9.9%) | $6.22 B(-8.7%) |
| June 2020 | - | $1.83 B(-5.9%) | $6.81 B(-9.9%) |
| Mar 2020 | - | $1.94 B(+337.9%) | $7.56 B(-6.1%) |
| Dec 2019 | $8.05 B(-10.4%) | $443.00 M(-83.0%) | $8.05 B(-4.4%) |
| Sept 2019 | - | $2.60 B(+1.0%) | $8.43 B(-1.1%) |
| June 2019 | - | $2.58 B(+5.9%) | $8.52 B(-3.8%) |
| Mar 2019 | - | $2.43 B(+198.9%) | $8.86 B(-1.4%) |
| Dec 2018 | $8.99 B(-20.0%) | $814.00 M(-69.8%) | $8.99 B(-21.4%) |
| Sept 2018 | - | $2.69 B(-7.6%) | $11.43 B(-1.3%) |
| June 2018 | - | $2.92 B(+13.8%) | $11.58 B(+2.3%) |
| Mar 2018 | - | $2.56 B(-21.3%) | $11.32 B(+0.8%) |
| Dec 2017 | $11.23 B(-8.9%) | $3.26 B(+14.5%) | $11.23 B(+0.4%) |
| Sept 2017 | - | $2.84 B(+6.9%) | $11.18 B(-2.1%) |
| June 2017 | - | $2.66 B(+7.8%) | $11.42 B(-4.3%) |
| Mar 2017 | - | $2.47 B(-23.1%) | $11.94 B(-3.1%) |
| Dec 2016 | $12.32 B(+27.7%) | $3.21 B(+4.1%) | $12.32 B(-1.6%) |
| Sept 2016 | - | $3.08 B(-2.8%) | $12.52 B(+7.4%) |
| June 2016 | - | $3.17 B(+11.3%) | $11.65 B(+9.3%) |
| Mar 2016 | - | $2.85 B(-16.4%) | $10.66 B(+10.5%) |
| Dec 2015 | $9.65 B(+0.7%) | $3.41 B(+53.7%) | $9.65 B(+7.9%) |
| Sept 2015 | - | $2.22 B(+1.8%) | $8.94 B(-1.6%) |
| June 2015 | - | $2.18 B(+18.6%) | $9.09 B(-3.0%) |
| Mar 2015 | - | $1.84 B(-32.0%) | $9.37 B(-2.2%) |
| Dec 2014 | $9.58 B(-0.1%) | $2.70 B(+14.1%) | $9.58 B(-1.0%) |
| Sept 2014 | - | $2.37 B(-3.8%) | $9.67 B(+0.8%) |
| June 2014 | - | $2.46 B(+20.4%) | $9.59 B(+2.3%) |
| Mar 2014 | - | $2.04 B(-26.8%) | $9.37 B(-2.3%) |
| Dec 2013 | $9.59 B(-2.4%) | $2.79 B(+22.2%) | $9.59 B(+0.4%) |
| Sept 2013 | - | $2.29 B(+2.0%) | $9.54 B(-0.2%) |
| June 2013 | - | $2.24 B(-0.9%) | $9.57 B(-1.4%) |
| Mar 2013 | - | $2.26 B(-17.8%) | $9.70 B(-4.7%) |
| Dec 2012 | $9.82 B(-21.4%) | $2.75 B(+19.2%) | $10.18 B(+7.4%) |
| Sept 2012 | - | $2.31 B(-2.8%) | $9.48 B(-10.4%) |
| June 2012 | - | $2.38 B(-13.4%) | $10.58 B(-10.1%) |
| Mar 2012 | - | $2.75 B(+33.8%) | $11.78 B(-7.5%) |
| Dec 2011 | $12.50 B(-15.5%) | $2.05 B(-39.8%) | $12.72 B(-7.7%) |
| Sept 2011 | - | $3.41 B(-4.5%) | $13.79 B(-2.7%) |
| June 2011 | - | $3.57 B(-3.3%) | $14.17 B(-0.8%) |
| Mar 2011 | - | $3.69 B(+18.7%) | $14.28 B(-3.4%) |
| Dec 2010 | $14.79 B(+66.4%) | $3.11 B(-17.9%) | $14.79 B(-5.3%) |
| Sept 2010 | - | $3.79 B(+2.9%) | $15.61 B(+14.7%) |
| June 2010 | - | $3.68 B(-12.3%) | $13.61 B(+16.5%) |
| Mar 2010 | - | $4.20 B(+6.8%) | $11.68 B(+31.4%) |
| Dec 2009 | $8.89 B(+9.6%) | $3.94 B(+120.0%) | $8.89 B(+33.3%) |
| Sept 2009 | - | $1.79 B(+1.9%) | $6.67 B(-4.8%) |
| June 2009 | - | $1.76 B(+24.7%) | $7.00 B(-7.1%) |
| Mar 2009 | - | $1.41 B(-17.9%) | $7.53 B(-7.1%) |
| Dec 2008 | $8.11 B(-27.8%) | $1.72 B(-19.2%) | $8.11 B(-10.1%) |
| Sept 2008 | - | $2.12 B(-7.3%) | $9.02 B(-21.7%) |
| June 2008 | - | $2.29 B(+15.3%) | $11.52 B(+1.6%) |
| Mar 2008 | - | $1.99 B(-24.3%) | $11.34 B(+0.9%) |
| Dec 2007 | $11.24 B(+47.1%) | $2.63 B(-43.2%) | $11.24 B(+3.8%) |
| Sept 2007 | - | $4.62 B(+119.0%) | $10.83 B(+32.5%) |
| June 2007 | - | $2.11 B(+11.8%) | $8.18 B(+4.1%) |
| Mar 2007 | - | $1.89 B(-14.9%) | $7.86 B(+2.8%) |
| Dec 2006 | $7.64 B | $2.22 B(+13.0%) | $7.64 B(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2006 | - | $1.96 B(+9.6%) | $7.41 B(+5.0%) |
| June 2006 | - | $1.79 B(+7.1%) | $7.05 B(+0.4%) |
| Mar 2006 | - | $1.67 B(-15.7%) | $7.03 B(-6.9%) |
| Dec 2005 | $7.23 B(+13.2%) | $1.98 B(+23.0%) | $7.55 B(+11.5%) |
| Sept 2005 | - | $1.61 B(-8.6%) | $6.77 B(-0.4%) |
| June 2005 | - | $1.76 B(-19.6%) | $6.80 B(+0.1%) |
| Mar 2005 | - | $2.19 B(+81.7%) | $6.79 B(+6.2%) |
| Dec 2004 | $6.39 B(-33.4%) | $1.21 B(-26.5%) | $6.39 B(-24.4%) |
| Sept 2004 | - | $1.64 B(-6.4%) | $8.45 B(-16.3%) |
| June 2004 | - | $1.75 B(-2.3%) | $10.10 B(-2.2%) |
| Mar 2004 | - | $1.79 B(-45.1%) | $10.32 B(+7.6%) |
| Dec 2003 | $9.59 B(+138.9%) | $3.27 B(-0.6%) | $9.60 B(+28.3%) |
| Sept 2003 | - | $3.29 B(+65.9%) | $7.48 B(+43.3%) |
| June 2003 | - | $1.98 B(+85.9%) | $5.22 B(+26.0%) |
| Mar 2003 | - | $1.06 B(-7.1%) | $4.14 B(+3.1%) |
| Dec 2002 | $4.01 B(+5.0%) | $1.15 B(+11.8%) | $4.01 B(+27.9%) |
| Sept 2002 | - | $1.03 B(+13.7%) | $3.14 B(-4.6%) |
| June 2002 | - | $902.00 M(-4.0%) | $3.29 B(-7.0%) |
| Mar 2002 | - | $940.00 M(+245.6%) | $3.54 B(-7.4%) |
| Dec 2001 | $3.82 B(-23.6%) | $272.00 M(-76.9%) | $3.82 B(-22.3%) |
| Sept 2001 | - | $1.18 B(+2.3%) | $4.92 B(-0.9%) |
| June 2001 | - | $1.15 B(-6.0%) | $4.96 B(-0.6%) |
| Mar 2001 | - | $1.22 B(-10.7%) | $5.00 B(+4.9%) |
| Dec 2000 | $5.01 B(+7.4%) | $1.37 B(+12.2%) | $4.76 B(+1.6%) |
| Sept 2000 | - | $1.22 B(+3.5%) | $4.69 B(-4.3%) |
| June 2000 | - | $1.18 B(+19.0%) | $4.90 B(+2.4%) |
| Mar 2000 | - | $992.00 M(-23.3%) | $4.78 B(+13.7%) |
| Dec 1999 | $4.66 B(+10.6%) | $1.29 B(-9.5%) | $4.21 B(-31.8%) |
| Sept 1999 | - | $1.43 B(+34.5%) | $6.17 B(+22.5%) |
| June 1999 | - | $1.06 B(+154.3%) | $5.04 B(+16.5%) |
| Mar 1999 | - | $418.00 M(-87.2%) | $4.32 B(+2.2%) |
| Dec 1998 | $4.21 B(+212.7%) | $3.26 B(+993.3%) | $4.23 B(+203.3%) |
| Sept 1998 | - | $298.00 M(-14.9%) | $1.40 B(+0.2%) |
| June 1998 | - | $350.00 M(+7.7%) | $1.39 B(-2.1%) |
| Mar 1998 | - | $325.00 M(-23.0%) | $1.42 B(-6.9%) |
| Dec 1997 | $1.35 B(+0.9%) | $422.00 M(+43.1%) | $1.53 B(+27.9%) |
| Sept 1997 | - | $295.00 M(-22.4%) | $1.20 B(-9.5%) |
| June 1997 | - | $380.00 M(-11.8%) | $1.32 B(-2.6%) |
| Mar 1997 | - | $431.00 M(+384.3%) | $1.35 B(+1.4%) |
| Dec 1996 | $1.34 B(-25.4%) | $89.00 M(-78.8%) | $1.34 B(-21.7%) |
| Sept 1996 | - | $420.00 M(+1.2%) | $1.71 B(-3.2%) |
| June 1996 | - | $415.00 M(+0.7%) | $1.76 B(-5.3%) |
| Mar 1996 | - | $412.00 M(-10.4%) | $1.86 B(-1.3%) |
| Dec 1995 | $1.79 B(+10.1%) | $459.60 M(-3.4%) | $1.88 B(-0.4%) |
| Sept 1995 | - | $475.60 M(-7.3%) | $1.89 B(+3.9%) |
| June 1995 | - | $512.80 M(+17.6%) | $1.82 B(+7.0%) |
| Mar 1995 | - | $435.90 M(-6.8%) | $1.70 B(+4.6%) |
| Dec 1994 | $1.63 B(+7.5%) | $467.90 M(+15.6%) | $1.63 B(+3.8%) |
| Sept 1994 | - | $404.80 M(+2.6%) | $1.57 B(+2.1%) |
| June 1994 | - | $394.40 M(+9.2%) | $1.54 B(+1.3%) |
| Mar 1994 | - | $361.10 M(-11.5%) | $1.52 B(-0.0%) |
| Dec 1993 | $1.51 B(-14.0%) | $408.10 M(+9.5%) | $1.52 B(-3.2%) |
| Sept 1993 | - | $372.70 M(-0.3%) | $1.57 B(-5.0%) |
| June 1993 | - | $374.00 M(+3.5%) | $1.65 B(-3.3%) |
| Mar 1993 | - | $361.30 M(-21.0%) | $1.70 B(-3.3%) |
| Dec 1992 | $1.76 B(-10.0%) | $457.60 M(+0.5%) | $1.76 B(-5.2%) |
| Sept 1992 | - | $455.10 M(+5.9%) | $1.86 B(-1.5%) |
| June 1992 | - | $429.90 M(+2.3%) | $1.89 B(-1.4%) |
| Mar 1992 | - | $420.30 M(-24.1%) | $1.91 B(-2.2%) |
| Dec 1991 | $1.96 B(-3.8%) | $553.40 M(+14.6%) | $1.96 B(-2.2%) |
| Sept 1991 | - | $482.70 M(+5.7%) | $2.00 B(-1.6%) |
| June 1991 | - | $456.50 M(-1.6%) | $2.03 B(-1.0%) |
| Mar 1991 | - | $463.90 M(-22.4%) | $2.05 B(+1.0%) |
| Dec 1990 | $2.03 B(+9.7%) | $597.90 M(+15.9%) | $2.03 B(+41.6%) |
| Sept 1990 | - | $515.90 M(+8.3%) | $1.44 B(+56.1%) |
| June 1990 | - | $476.20 M(+7.3%) | $920.20 M(+107.3%) |
| Mar 1990 | - | $444.00 M | $444.00 M |
| Dec 1989 | $1.86 B(+1.6%) | - | - |
| Dec 1988 | $1.83 B(+5.2%) | - | - |
| Dec 1987 | $1.73 B(+10.3%) | - | - |
| Dec 1986 | $1.57 B(+11.1%) | - | - |
| Dec 1985 | $1.42 B(+1.4%) | - | - |
| Dec 1984 | $1.40 B | - | - |
FAQ
- What is Pfizer annual cost of goods sold?
- What is the all time high annual cost of goods sold for Pfizer?
- What is Pfizer annual cost of goods sold year-on-year change?
- What is Pfizer quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Pfizer?
- What is Pfizer quarterly cost of goods sold year-on-year change?
- What is Pfizer TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Pfizer?
- What is Pfizer TTM cost of goods sold year-on-year change?
What is Pfizer annual cost of goods sold?
The current annual cost of goods sold of PFE is $24.95 B
What is the all time high annual cost of goods sold for Pfizer?
Pfizer all-time high annual cost of goods sold is $34.34 B
What is Pfizer annual cost of goods sold year-on-year change?
Over the past year, PFE annual cost of goods sold has changed by -$9.39 B (-27.34%)
What is Pfizer quarterly cost of goods sold?
The current quarterly cost of goods sold of PFE is $5.26 B
What is the all time high quarterly cost of goods sold for Pfizer?
Pfizer all-time high quarterly cost of goods sold is $9.98 B
What is Pfizer quarterly cost of goods sold year-on-year change?
Over the past year, PFE quarterly cost of goods sold has changed by -$4.01 B (-43.22%)
What is Pfizer TTM cost of goods sold?
The current TTM cost of goods sold of PFE is $19.50 B
What is the all time high TTM cost of goods sold for Pfizer?
Pfizer all-time high TTM cost of goods sold is $38.30 B
What is Pfizer TTM cost of goods sold year-on-year change?
Over the past year, PFE TTM cost of goods sold has changed by -$7.54 B (-27.87%)